The benefit and risk of addition of chemotherapy to EGFR tyrosine kinase inhibitors for EGFR-positive non-small cell lung cancer patients with brain metastases: a meta-analysis based on randomized controlled trials - Chen, Zhigang; Fu, Xiang; Zhu, Lingping; Wen, Xiurong; Zhang, Shihao (Frontiers in oncology, 2024)
Keywords: brain metastases; chemotherapy; EGFR; meta-analysis; non-small cell lung cancer; Oncology; tyrosine kinase inhibitors; non-small cell lung cancer; tyrosine kinase inhibitors; meta-analysis; chemotherapy; brain metastases; EGFR